BREANNE FLUSCHE: Open Payments
NPI 1013532209 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,747 in 78 payments from 17 companies in 2025. Trend: 2023 $189 · 2024 $751 · 2025 $1,747
Food & beverage: $1,747
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $481 |
| Xeris Pharmaceuticals, Inc. | 10 | $230 |
| Radius Health, Inc. | 7 | $223 |
| Corcept Therapeutics | 10 | $212 |
| Novo Nordisk Inc | 6 | $104 |
| Alexion Pharmaceuticals, Inc. | 5 | $98 |
| Almatica Pharma LLC | 3 | $71 |
| Intra-Sana Laboratories | 4 | $65 |
| ABBVIE INC. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
Products named: EVENITY, Tymlos, Korlym, RECORLEV, Wegovy, TERIPARATIDE, RELTONE 200 MG, STRENSIQ.
Industry payments across OK — which companies pay providers there.
